142 related articles for article (PubMed ID: 24120541)
1. Synthesis, structure analysis, antitumor evaluation and 3D-QSAR studies of 3,6-disubstituted-dihydro-1,2,4,5-tetrazine derivatives.
Rao GW; Wang C; Wang J; Zhao ZG; Hu WX
Bioorg Med Chem Lett; 2013 Dec; 23(23):6474-80. PubMed ID: 24120541
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antitumor evaluation and 3D-QSAR studies of [1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine derivatives.
Xu F; Yang ZZ; Ke ZL; Xi LM; Yan QD; Yang WQ; Zhu LQ; Lin FL; Lv WK; Wu HG; Wang J; Li HB
Bioorg Med Chem Lett; 2016 Oct; 26(19):4580-4586. PubMed ID: 27597251
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structure analysis, and antitumor activity of 3,6-disubstituted-1,4-dihydro-1,2,4,5-tetrazine derivatives.
Rao GW; Hu WX
Bioorg Med Chem Lett; 2006 Jul; 16(14):3702-5. PubMed ID: 16709456
[TBL] [Abstract][Full Text] [Related]
4. [Synthesis and antineoplastic activity of N,N'-disubstituted phenyl-3,6-dimethyl-1,4-dihydro-1,2,4,5-tetrazine-1,4-dicarboamide derivatives].
Cai ZB; Zhou M; Hu WX; Yang ZY
Yao Xue Xue Bao; 2000 Oct; 35(10):793-6. PubMed ID: 11372451
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, X-ray crystallographic analysis, and antitumor activity of 1-acyl-3,6-disubstituted phenyl-1,4-dihydro-1,2,4,5-tetrazines.
Rao GW; Hu WX
Bioorg Med Chem Lett; 2005 Jun; 15(12):3174-6. PubMed ID: 15908202
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, antifungal evaluation and 3D-QSAR study of phenylhydrazine substituted tetronic acid derivatives.
Hu Y; Wang J; Lu A; Yang C
Bioorg Med Chem Lett; 2014 Aug; 24(16):3772-6. PubMed ID: 25042337
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of s-tetrazine derivatives.
Hu WX; Rao GW; Sun YQ
Bioorg Med Chem Lett; 2004 Mar; 14(5):1177-81. PubMed ID: 14980660
[TBL] [Abstract][Full Text] [Related]
8. Understanding the antitumor activity of novel tricyclicpiperazinyl derivatives as farnesyltransferase inhibitors using CoMFA and CoMSIA.
Puntambekar DS; Giridhar R; Yadav MR
Eur J Med Chem; 2006 Nov; 41(11):1279-92. PubMed ID: 16919851
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and 3D-QSAR of beta-carboline derivatives as potent antitumor agents.
Cao R; Guan X; Shi B; Chen Z; Ren Z; Peng W; Song H
Eur J Med Chem; 2010 Jun; 45(6):2503-15. PubMed ID: 20304536
[TBL] [Abstract][Full Text] [Related]
10. 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme.
Adane L; Bharatam PV
J Mol Graph Model; 2009 Nov; 28(4):357-67. PubMed ID: 19796975
[TBL] [Abstract][Full Text] [Related]
11. 3D QSAR CoMFA/CoMSIA and docking studies on azole dione derivatives, as anti-cancer inhibitors.
Anugolu RK; Gunda SK; Mahmood S
Int J Comput Biol Drug Des; 2012; 5(2):111-36. PubMed ID: 22854121
[TBL] [Abstract][Full Text] [Related]
12. Predicting anti-cancer activity of quinoline derivatives: CoMFA and CoMSIA approach.
Vaidya A; Jain AK; Kumar P; Kashaw SK; Agrawal RK
J Enzyme Inhib Med Chem; 2011 Dec; 26(6):854-61. PubMed ID: 21476832
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, structure analysis, and antitumor evaluation of 3,6-dimethyl-1,2,4,5-tetrazine-1,4-dicarboxamide derivatives.
Rao GW; Guo YM; Hu WX
ChemMedChem; 2012 Jun; 7(6):973-6. PubMed ID: 22539490
[TBL] [Abstract][Full Text] [Related]
14. 3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA.
Xue CX; Cui SY; Liu MC; Hu ZD; Fan BT
Eur J Med Chem; 2004 Sep; 39(9):745-53. PubMed ID: 15337287
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional quantitative structure-activity relationship (3D-QSAR) analyses of choline acetyltransferase inhibitors.
Chandrasekaran V; McGaughey GB; Cavallito CJ; Bowen JP
J Mol Graph Model; 2004 Sep; 23(1):69-76. PubMed ID: 15331055
[TBL] [Abstract][Full Text] [Related]
16. The 3D-QSAR study of antitumor arylsulfonylimidazolidinone derivatives by CoMFA and CoMSIA.
Choo HY; Choi S; Jung SH; Koh HY; Pae AN
Bioorg Med Chem; 2003 Oct; 11(21):4585-9. PubMed ID: 14527555
[TBL] [Abstract][Full Text] [Related]
17. Understanding the antitumor activity of novel hydroxysemicarbazide derivatives as ribonucleotide reductase inhibitors using CoMFA and CoMSIA.
Raichurkar AV; Kulkarni VM
J Med Chem; 2003 Oct; 46(21):4419-27. PubMed ID: 14521406
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models.
Vyas VK; Gupta N; Ghate M; Patel S
SAR QSAR Environ Res; 2014; 25(2):117-46. PubMed ID: 24598006
[TBL] [Abstract][Full Text] [Related]
19. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.
Lu P; Wei X; Zhang R
Eur J Med Chem; 2010 Aug; 45(8):3413-9. PubMed ID: 20488589
[TBL] [Abstract][Full Text] [Related]
20. 3D-QSAR studies on triazolopiperazine amide inhibitors of dipeptidyl peptidase-IV as anti-diabetic agents.
Saqib U; Siddiqi MI
SAR QSAR Environ Res; 2009 Jul; 20(5-6):519-35. PubMed ID: 19916112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
